Suppr超能文献

相似文献

1
Improving access to screening and treatment of hepatocellular carcinoma in the United States.
Clin Liver Dis (Hoboken). 2024 Jun 5;23(1):e0219. doi: 10.1097/CLD.0000000000000219. eCollection 2024 Jan-Jun.
2
Is Screening for Hepatocellular Carcinoma Effective?
Adv Surg. 2023 Sep;57(1):73-86. doi: 10.1016/j.yasu.2023.03.003. Epub 2023 Apr 28.
3
[Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2021 Oct 20;29(10):942-947. doi: 10.3760/cma.j.cn501113-20210927-00485.
4
An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma.
J Hepatocell Carcinoma. 2021 Sep 28;8:1209-1219. doi: 10.2147/JHC.S284430. eCollection 2021.
5
Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
Am J Med. 2017 Sep;130(9):1099-1106.e1. doi: 10.1016/j.amjmed.2017.01.021. Epub 2017 Feb 14.
8
Hepatocellular carcinoma: diagnosis and treatment.
Gastroenterology. 2002 May;122(6):1609-19. doi: 10.1053/gast.2002.33411.
9
[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017].
Bull Cancer. 2017 Sep;104(9):752-761. doi: 10.1016/j.bulcan.2017.06.008. Epub 2017 Jul 24.

引用本文的文献

本文引用的文献

1
Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.
Clin Gastroenterol Hepatol. 2024 Feb;22(2):295-304.e2. doi: 10.1016/j.cgh.2023.08.003. Epub 2023 Aug 12.
2
Multidisciplinary care for patients with HCC: a systematic review and meta-analysis.
Hepatol Commun. 2023 Apr 26;7(5). doi: 10.1097/HC9.0000000000000143. eCollection 2023 May 1.
3
Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
Dig Dis Sci. 2023 May;68(5):1791-1796. doi: 10.1007/s10620-022-07786-0. Epub 2022 Dec 23.
4
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis.
JHEP Rep. 2021 Nov 4;4(1):100390. doi: 10.1016/j.jhepr.2021.100390. eCollection 2022 Jan.
5
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
7
Novel Calculators for Risk Stratification in Hepatocellular Carcinoma: A Concise Review.
J Clin Gastroenterol. 2020 Oct;54(9):789-794. doi: 10.1097/MCG.0000000000001406.
9
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.
10
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Gastroenterology. 2017 Jun;152(8):1954-1964. doi: 10.1053/j.gastro.2017.02.040. Epub 2017 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验